Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed.
This topic was the focus of a breakout session at Outcomes+ 2022.
Taking a whole-person approach to care leads to healthier people and more affordable plans.
A clinically based, expertly evaluated platform of digital health solutions to address your plan’s most pressing challenges. Each solution on the Evernorth Digital Health Formulary has been clinically reviewed and evaluated through our streamlined and rigorous review process.
Evernorth Geographic Social Determinants Index (EGSDI) identifies opportunities for proactive patient and community engagement for individuals diagnosed with type 2 diabetes.
Every journey to start a family is different but no less financially and emotionally stressful.